RE:Generics co Ani Pharm SP goes from $6.00 to $55 in a yrAni 's rapid browth from a startup to about $1 Billion CDN market cap, in just over a year, was done on the back of deal making in the generics space --- both traditional and specialty generics... It underscores the massive opportunities for deal making in the generics sector now, and also my view that NPH's existing portfolia is just a start, and gives them the platform and credibility, to successfully pursue strategic deals for NPH... BTW Ani has something in common with another company I talked about, Akorn Pharma, since Ani recently got Akorns past CEO.. I think it will be even easier for NPH to land deals , than Like for ANI, since the US market is the golden plam of markets and always is in high demand...Generics in Canada is right now an undiscovered gem, off the radar a bit, and so rights in many cases will be given away for free , or very cheap... yes you heard that corect.. the secrt is in the deal making...and I want NPH to be a talented dealmaker...and everything is fitting into place..